How EV + Pembrolizumab is Changing Bladder Cancer Care

Join Vic Senese, RN, BSN, FAUNA, host of UroPatient, as we explore the groundbreaking combination therapy EV + Pembrolizumab for advanced urothelial carcinoma (bladder cancer). In this video, Vic explains in clear, patient-friendly terms how Enfortumab Vedotin targets cancer cells directly while Pembrolizumab empowers the immune system to attack tumors, improving survival and tumor response rates. Learn about who can receive this treatment, what to expect during therapy, common side effects, and tips for managing them effectively. Whether you are a patient, caregiver, or healthcare enthusiast, this video provides an accessible overview of one of the most promising new options in bladder cancer care. Subscribe to the UroNurse channel for more updates, expert insights, and patient-focused education:    / @uronurse1   The expert's opinions in this communication are personal and not representative of any organization. They are for informational purposes only, not official guidance. Viewers are advised to use their judgment, seek additional advice, and take responsibility for any actions based on these opinions.